Radiotherapy and implanted materials - what is safe?
Loading player...
Be informed with René Botha.
René Botha explains the impact that implanted materials have on radiotherapy treatment.
This episode is brought to you by Accord Healthcare in the interest of education, awareness, and support. The content and opinions expressed are entirely those of the healthcare professional and not influenced by Accord Healthcare in any way.
Accord Healthcare is one of the fastest-growing generic pharmaceutical companies with a direct presence in all major markets, Americas, the EU, Asia, and Africa. Accord Healthcare is an Oncology leader with a 30% global volume share of major chemotherapy molecules. The cornerstone of Accord’s offering to the South African market is exceptional quality, affordability and service to healthcare professionals and their patients.
René Botha is a radiotherapist with a special interest in treatment planning. She works in private practice and is based at the Wits University Donald Gordon Medical Centre.
René Botha explains the impact that implanted materials have on radiotherapy treatment.
This episode is brought to you by Accord Healthcare in the interest of education, awareness, and support. The content and opinions expressed are entirely those of the healthcare professional and not influenced by Accord Healthcare in any way.
Accord Healthcare is one of the fastest-growing generic pharmaceutical companies with a direct presence in all major markets, Americas, the EU, Asia, and Africa. Accord Healthcare is an Oncology leader with a 30% global volume share of major chemotherapy molecules. The cornerstone of Accord’s offering to the South African market is exceptional quality, affordability and service to healthcare professionals and their patients.
René Botha is a radiotherapist with a special interest in treatment planning. She works in private practice and is based at the Wits University Donald Gordon Medical Centre.
